Minaris is a specialized global partner for therapy development, manufacturing, and testing, with dedicated business units in Cell Therapy, Viral Vectors, and Testing Services. With 5 sites across 3 continents, Minaris supports developers from early development through commercial manufacturing with integrated plasmid and vector design, cGMP manufacturing, and comprehensive GMP testing services. Backed by 7,500+ GMP batches manufactured, commercial manufacturing experience across multiple products, 25+ years as a cell therapy and viral vector CDMO, and 40+ years as a contract testing provider, Minaris brings the scale, technical expertise, and quality infrastructure needed to advance complex therapies with confidence. Capabilities span cell therapies, viral vectors, analytical development, cell banking, lot release, potency testing, stability studies, and viral clearance, supported by 1,700+ assays developed and 30+ successful global health authority inspections.
Download the flyer to learn how Minaris can serve as your integrated partner from discovery to delivery, IND to BLA, and local to global commercialization.
